2001
DOI: 10.1016/s0021-9673(01)01088-3
|View full text |Cite
|
Sign up to set email alerts
|

Quantitation of monoterpenoid compounds with potential medicinal use in biological fluids

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
10
0

Year Published

2002
2002
2009
2009

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 16 publications
(10 citation statements)
references
References 48 publications
0
10
0
Order By: Relevance
“…Chemical ionization (CI) mass spectra of terpenes have been reported [18] but the SCI of terpenes has not been studied previously. We present the first detailed studies on the SCI of ␣-pinene and ␣ camphene; here, SCI is referred to the formation of [M ϩ H] ϩ by reaction of either its fragment or M ·ϩ ions with neutral parent molecules (M).…”
mentioning
confidence: 99%
“…Chemical ionization (CI) mass spectra of terpenes have been reported [18] but the SCI of terpenes has not been studied previously. We present the first detailed studies on the SCI of ␣-pinene and ␣ camphene; here, SCI is referred to the formation of [M ϩ H] ϩ by reaction of either its fragment or M ·ϩ ions with neutral parent molecules (M).…”
mentioning
confidence: 99%
“…Exposure to monoterpenes can be determined by biomonitoring of monoterpenes and/or monoterpene metabolites concentrations in biological fluids such as blood and urine from suspected exposed human subjects. The biomonitoring technique provides a very useful tool to estimate systemic uptake/exposure of man to monoterpenes and presents also an indication of the bioavailability of monoterpenes [16]. Previously, different studies reported the possibility of the determination of monoterpene systemic exposure by the analyses monoterpene alcohol concentrations from monoterpenes such as verbenol, a metabolite of ␣-pinene [17], 2␣-and 3␣-hydroxycineole [18] metabolites from 1,8-cineole and the 3 -carene metabolite, 3 -carene-10-ol [19] in urine samples.…”
Section: Introductionmentioning
confidence: 99%
“…In humans, few studies were performed to elucidate the pharmacokinetic profile of menthol and its main metabolite M-G, but not of other phase-I metabolites. For the quantification of menthol and M-G after enzymatic hydrolysis in plasma and urine different methods including liquid-liquid extraction or headspace sampling followed by analysis with GC and GC-MS were proposed [4][5][6][7][8][9][10]. In plasma unconjugated menthol was only detected after a transdermal application [5].…”
Section: Introductionmentioning
confidence: 99%
“…In plasma unconjugated menthol was only detected after a transdermal application [5]. The problem of methods basing on liquid-liquid extraction consists in loosing the lipophilic analytes by volatilisation [9], resulting in loss of recovery, sensitivity and precision. Concerning M-G, the use of high performance liquid chromatography (HPLC) for its direct determination would be an option to avoid such problems.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation